Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions

Ebola virus is responsible for causing severe hemorrhagic fevers, with case fatality rates of up to 90%. Currently, no antiviral or vaccine is licensed against Ebola virus. A phosphatidylserine-targeting antibody (PGN401, bavituximab) has previously been shown to have broad-spectrum antiviral activi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Res
Main Authors: Dowall, S. D., Graham, V. A., Corbin-Lickfett, K., Empig, C., Schlunegger, K., Bruce, C. B., Easterbrook, L., Hewson, R.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359806/
https://ncbi.nlm.nih.gov/pubmed/25815346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/347903
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados